Tangeretin

N/A

Report date: 2023/02/11 20:38:19

Base Information

Drug NameTangeretin
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionApoptosis stimulantsNuclear factor erythroid 2-related factor 2 stimulantsMitogen-activated protein kinase inhibitors
TargetsNuclear factor erythroid 2-related factor 2Mitogen-activated protein kinase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesFunakoshi Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesFunakoshi Ltd +[2] 
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A